Back
Structure Therapeutics Stock Predictions

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
46
GPCR
Structure Therapeutics
Last Price:
$24.05
Seasonality Move:
7.17%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.Structure Therapeutics Stock Forecast
-
Over the next 52 weeks, Structure Therapeutics has on average historically risen by 17.5% based on the past 2 years of stock performance.
-
Structure Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Structure Therapeutics Stock Undervalued?The current Structure Therapeutics [GPCR] share price is $24.62. The Score for GPCR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
GPCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Structure Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Structure Therapeutics has on average historically risen by 17.5% based on the past 2 years of stock performance.
Structure Therapeutics Stock Rating
Sell
46
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics overpriced?
-
Structure Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Structure Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
structuretx.com
52-Week Data
52-Week High:
62.74
52-Week Low:
13.22
Prediction Charts
Market Cap:
1.4B
Price in USD:
24.62
Volume:
684.4K
Beta:
-1.79
Technical Analysis
SMA50:
21.30
SMA100:
24.08
SMA200:
30.83
52-Wk Change:
-31.27%
Stock Predictions
-
Is Structure Therapeutics stock public?Yes, Structure Therapeutics is a publicly traded company.
-
What is the Structure Therapeutics stock quote today?The Structure Therapeutics stock price is 24.62 USD today.
-
How to buy Structure Therapeutics stock online?You can buy Structure Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-23 | 23.57 | 23.32 | 24.45 | 23.05 |
Apr-24 | 23.21 | 23.65 | 24.00 | 22.79 |
Apr-25 | 23.50 | 23.74 | 24.19 | 23.20 |
Apr-28 | 23.74 | 23.62 | 24.63 | 23.61 |
Apr-29 | 24.15 | 25.91 | 26.25 | 24.11 |
Apr-30 | 25.50 | 27.00 | 28.16 | 25.29 |
May-1 | 27.20 | 27.33 | 27.80 | 26.16 |
May-2 | 27.98 | 27.09 | 28.68 | 27.02 |
May-5 | 26.91 | 27.55 | 27.68 | 26.19 |
May-6 | 27.12 | 25.33 | 27.78 | 25.26 |
May-7 | 25.52 | 26.60 | 26.65 | 25.06 |
May-8 | 26.72 | 26.82 | 27.50 | 25.85 |
May-9 | 26.65 | 25.57 | 27.12 | 25.51 |
May-12 | 26.38 | 24.62 | 26.90 | 24.30 |
Structure Therapeutics Earnings
Structure Therapeutics Earnings Report: Per Share Structure Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Structure Therapeutics Forecast Revenue Growth
Structure Therapeutics Stock Analysis: Historical quarterly revenues per share for Structure Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.78 per share.
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.